Juan C. Jaen, the president of Arcus Biosciences ( RCUS 2.33%), sold 96,859 shares in multiple open-market transactions on Tuesday and Wednesday, according to an SEC Form 4 filing. The transaction ...
“Orelabrutinib has a differentiated mechanism of action and strong clinical data underscoring its promising potential as a treatment for patients with progressive forms of MS. We are confident in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback